株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

体外診断 (IVD) の世界市場予測 〜2023年:製品(器具、試薬)、技術(免疫測定、臨床化学、分子診断、血液学、尿分析)、用途(糖尿病、腫瘍/癌、心臓、腎臓)、地域別

In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023

発行 MarketsandMarkets 商品コード 239720
出版日 ページ情報 英文 407 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.84円で換算しております。
Back to Top
体外診断 (IVD) の世界市場予測 〜2023年:製品(器具、試薬)、技術(免疫測定、臨床化学、分子診断、血液学、尿分析)、用途(糖尿病、腫瘍/癌、心臓、腎臓)、地域別 In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023
出版日: 2018年03月27日 ページ情報: 英文 407 Pages
概要

世界のIVD市場は、2023年には879億3,000万米ドルの規模に達する見込みとなっており、2016年から2023年にかけてのCAGR (複合年間成長率) は5.2%になるものと予測されています。

当レポートでは、体外診断 (IVD) 市場を取り上げ、市場の概要、市場発展促進・阻害要因、市場における課題および機会を概括し、製品・技術・用途・地域別に市場の現状と見通しについて調査分析するとともに、競合環境、主要企業のプロファイルをまとめています。

第1章 イントロダクション

  • 調査の目的
  • 市場の定義
  • 市場の範囲
    • 網羅した市場
    • 調査の対象とした年
  • 通貨
  • 制約
  • ステークホルダー

第2章 調査手法

  • 調査データ
    • 一次データ
    • 二次データ
  • 市場規模推定
  • 市場内訳とデータの三角測量
  • 市場シェア推定
  • 調査の前提条件

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要
  • アジア太平洋のIVD市場:製品・サービス別
  • 地域概要
  • 地域ミックス
  • IDV市場:新興市場 vs 新興市場

第5章 体外診断 (IVD) の世界市場:概要

  • イントロダクション
  • 市場動態
    • 市場発展促進要因
      • 慢性生活習慣病の発生率の上昇
      • ラボオートメーションと完全自動装置の導入拡大
      • オーダーメイド医療の認知度の拡大
      • ポイントオブケア (POC) 検査の導入拡大
    • 市場発展阻害要因
      • 市場に不利な償還シナリオ
    • 市場機会
      • 症状に特化したマーカーおよび検査の開発
      • 重要性を増すコンパニオン新d何
      • 新興国の成長機会
    • 課題
      • 規制環境の変化

第6章 体外診断 (IVD) の世界市場:産業動向

  • イントロダクション
  • 産業動向
    • 臨床検査技術の自動化
    • 臨床検査向けマイクロ流体工学ベースのPoc/Loc診断装置
    • 試薬のレンタル契約の増加
  • 規制概要
    • 米国
    • カナダ
    • 欧州
    • 日本
    • 中国
    • インド
    • インドネシア
    • ロシア
    • サウジアラビア
    • メキシコ
    • ブラジル
    • 韓国
  • ベンダーベンチマーク

第7章 体外診断 (IVD) の世界市場:製品・サービス別

  • イントロダクション
  • 試薬とキット
  • 器具
  • データ管理ソフトウェア
  • サービス

第8章 体外診断 (IVD) の世界市場:技術別

  • イントロダクション
  • 免疫化学/免疫測定法
  • 臨床化学
  • 分子診断
  • 微生物学
  • 血液学
  • 透析・止血
  • 尿分析
  • その他

第9章 体外診断 (IVD) の世界市場:用途別

  • イントロダクション
  • 感染症
  • 糖尿病
  • 腫瘍/癌
  • 自己免疫疾患
  • 腎臓
  • 薬物検査
  • HIV/AIDS
  • 心臓
  • その他

第10章 体外診断 (IVD) の世界市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 研究所
  • ポイントオブケア (POC) 検査
  • 患者の自己検査
  • 学術機関
  • その他

第11章 体外診断 (IVD) の世界市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第12章 競合環境

  • 概要
  • 市場シェア分析
  • 競合状況・動向
    • 新製品発表
    • 合意、パートナーシップ、協業
    • 買収
    • 事業拡張
    • その他の戦略

第13章 企業プロファイル

  • イントロダクション
  • ROCHE DIAGNOSTICS
  • DANAHER CORPORATION
  • ABBOTT LABORATORIES, INC.
  • SIEMENS AG
  • SYSMEX CORPORATION
  • THERMO FISHER SCIENTIFIC
  • BECTON, DICKINSON AND COMPANY
  • BIOMERIEUX SA
  • BIO-RAD LABORATORIES, INC.
  • JOHNSON & JOHNSON
  • AGILENT TECHNOLOGIES
  • QIAGEN
  • DIASORIN
  • ORTHO CLINICAL DIAGNOSTICS

第14章 付録

目次
Product Code: MD 3609

"The in vitro diagnostics market is projected to grow at a CAGR of 5.2%."

The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories. Moreover, the development of condition-specific markers and tests, growing significance of companion diagnostics, and emerging economies are expected to offer significant growth opportunities for market players during the forecast period. However, the unfavorable reimbursement scenario, changing regulatory landscape, and operational barriers faced in conducting diagnostic tests are all expected to challenge market growth to a certain extent in the coming years.

"The reagents & kits segment is expected to dominate the market during the forecast period."

In 2018, on the basis of product & service, the reagents & kits segment is expected to account for the largest share of the market.The large share of this segment is primarily attributed to the increased accessibility and demand for reagents and the rising number of IVD tests conducted.

"The oncology segment is projected to be the fastest growing during the forecast period."

In 2018, on the basis of application, the oncology segment is expected to register the highest growth rate during the forecast period, owing to the increasing prevalence of cancer and the introduction of a number of diagnostic tests such as Oncomine Dx Target Test and Oncomine Solid Tumor kits (Thermo Fisher Scientific) for NSCLC and PTEN/ERG FISH and UroVysion FISH tests for the detection of bladder cancer and treatment assessment of prostate cancer.

"Asia Pacific is expected to register the highest growth rate during the forecast period."

In this report, the IVD market is divided into five major regions-North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period owing to the huge demand for better healthcare services; increasing incidence of chronic and infectious diseases; rapid development in the healthcare infrastructure of developing countries such as India, China, and South Korea; growing healthcare research investments in this region; and increasing per capita income of the middle-class population in the region.

Breakdown of supply-side primary interviews: by company type, designation, and region:

  • By Company Type - Tier 1 - 22%, Tier 2 - 53% and Tier 3 - 25%
  • By Designation - C-level - 45%, Director-level - 30%, Others - 25%
  • By Region - North America - 55%, Europe - 25%, APAC - 10%, Latin America- 5%, and Middle East & Africa - 5%

List of companies profiled in the report:

  • Roche Diagnostics (Switzerland)
  • Siemens Healthineers (Germany)
  • Danaher Corporation (US)
  • Abbott Laboratories (US)
  • Thermo Fisher Scientific (US)
  • Johnson & Johnson (US)
  • Becton, Dickinson and Company (US)
  • Bio-Rad Laboratories (US)
  • Sysmex Corporation (Japan)
  • bioMerieux (France)
  • DiaSorin (Italy)
  • Ortho Clinical Diagnostics (US)
  • QIAGEN (Germany)
  • Agilent Technologies (US)

Research Coverage:

This report studies the in vitro diagnostics market based on product & service, technology, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall in vitro diagnostics market and its segments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Breakdown of primaries
      • 2.1.2.2 Key data from primary sources
      • 2.1.2.3 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 IN VITRO DIAGNOSTICS (IVD) MARKET OVERVIEW
  • 4.2 ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
  • 4.3 GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET
  • 4.4 GEOGRAPHIC MIX: IN VITRO DIAGNOSTICS MARKET
  • 4.5 IN VITRO DIAGNOSTICS MARKET: DEVELOPING VS. DEVELOPED MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases
      • 5.2.1.2 Increasing adoption of fully automated instruments and automation in laboratories
      • 5.2.1.3 Growing awareness on personalized medicine
      • 5.2.1.4 Increasing adoption of point-of-care testing
    • 5.2.2 RESTRAINT
      • 5.2.2.1 Unfavorable reimbursement scenario
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Development of condition-specific markers and tests
      • 5.2.3.2 Growing significance of companion diagnostics
      • 5.2.3.3 Growth opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Changing regulatory landscape
      • 5.2.4.2 Operational barriers faced in conducting diagnostic tests

6 INDUSTRY INSIGHTS

  • 6.1 INTRODUCTION
  • 6.2 INDUSTRY TRENDS
    • 6.2.1 AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
    • 6.2.2 MICROFLUIDICS-BASED POC AND LOC DIAGNOSTIC DEVICES FOR LABORATORY TESTING
    • 6.2.3 RISE IN NUMBER OF REAGENT RENTAL AGREEMENTS
  • 6.3 REGULATORY OVERVIEW
    • 6.3.1 US
    • 6.3.2 CANADA
    • 6.3.3 EUROPE
    • 6.3.4 JAPAN
    • 6.3.5 CHINA
    • 6.3.6 INDIA
    • 6.3.7 INDONESIA
    • 6.3.8 RUSSIA
    • 6.3.9 SAUDI ARABIA
    • 6.3.10 MEXICO
    • 6.3.11 BRAZIL
    • 6.3.12 SOUTH KOREA
  • 6.4 VENDOR BENCHMARKING

7 IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 7.1 INTRODUCTION
  • 7.2 REAGENTS & KITS
  • 7.3 INSTRUMENTS
    • 7.3.1 FULLY AUTOMATED INSTRUMENTS
    • 7.3.2 SEMI-AUTOMATED INSTRUMENTS
    • 7.3.3 OTHER INSTRUMENTS
  • 7.4 DATA MANAGEMENT SOFTWARE
  • 7.5 SERVICES

8 IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
  • 8.2 IMMUNOASSAY/IMMUNOCHEMISTRY
    • 8.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY
      • 8.2.1.1 Chemiluminescence immunoassays
      • 8.2.1.2 Fluorescence immunoassays
      • 8.2.1.3 Colorimetric immunoassays
    • 8.2.2 RADIOIMMUNOASSAY
    • 8.2.3 RAPID TEST
    • 8.2.4 WESTERN BLOTTING
    • 8.2.5 ENZYME-LINKED IMMUNOSPOT ASSAYS
  • 8.3 CLINICAL CHEMISTRY
    • 8.3.1 BASIC METABOLIC PANEL
    • 8.3.2 ELECTROLYTE PANEL
    • 8.3.3 LIVER PANEL
    • 8.3.4 LIPID PROFILE
    • 8.3.5 RENAL PROFILE
    • 8.3.6 THYROID FUNCTION PANEL
    • 8.3.7 SPECIALTY CHEMICAL TESTS
  • 8.4 MOLECULAR DIAGNOSTICS
    • 8.4.1 POLYMERASE CHAIN REACTION
    • 8.4.2 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY
    • 8.4.3 MICROARRAY
    • 8.4.4 HYBRIDIZATION
    • 8.4.5 DNA SEQUENCING & NEXT-GENERATION SEQUENCING
    • 8.4.6 OTHER MDX TECHNOLOGIES
  • 8.5 MICROBIOLOGY
  • 8.6 HEMATOLOGY
  • 8.7 COAGULATION AND HEMOSTASIS
  • 8.8 URINALYSIS
  • 8.9 OTHER IVD TECHNOLOGIES

9 IN VITRO DIAGNOSTICS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
  • 9.2 INFECTIOUS DISEASES
  • 9.3 DIABETES
  • 9.4 ONCOLOGY
  • 9.5 CARDIOLOGY
  • 9.6 AUTOIMMUNE DISEASES
  • 9.7 NEPHROLOGY
  • 9.8 DRUG TESTING/PHARMACOGENOMICS
  • 9.9 HIV/AIDS
  • 9.10 OTHER APPLICATIONS

10 IN VITRO DIAGNOSTICS MARKET, BY END USER

  • 10.1 INTRODUCTION
  • 10.2 HOSPITALS
  • 10.3 LABORATORIES
    • 10.3.1 LARGE/REFERENCE LABORATORIES
    • 10.3.2 MEDIUM-SIZED LABORATORIES
    • 10.3.3 SMALL LABORATORIES
  • 10.4 POINT-OF-CARE TESTING
  • 10.5 PATIENT SELF-TESTING
  • 10.6 ACADEMIC INSTITUTES
  • 10.7 OTHER END USERS

11 IN VITRO DIAGNOSTICS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
    • 11.2.2 CANADA
  • 11.3 EUROPE
    • 11.3.1 GERMANY
    • 11.3.2 FRANCE
    • 11.3.3 UK
    • 11.3.4 ITALY
    • 11.3.5 SPAIN
    • 11.3.6 RUSSIA
    • 11.3.7 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 JAPAN
    • 11.4.2 CHINA
    • 11.4.3 INDIA
    • 11.4.4 SOUTH KOREA
    • 11.4.5 INDONESIA
    • 11.4.6 REST OF ASIA PACIFIC
  • 11.5 LATIN AMERICA
    • 11.5.1 BRAZIL
    • 11.5.2 MEXICO
    • 11.5.3 REST OF LATIN AMERICA
  • 11.6 MIDDLE EAST & AFRICA
    • 11.6.1 SAUDI ARABIA
    • 11.6.2 REST OF THE MIDDLE EAST & AFRICA

12 COMPETITIVE LANDSCAPE

  • 12.1 INTRODUCTION
  • 12.2 MARKET SHARE ANALYSIS
    • 12.2.1 MARKET SHARE ANALYSIS, BY TECHNOLOGY
      • 12.2.1.1 Clinical chemistry
      • 12.2.1.2 Immunochemistry/Immunoassay
      • 12.2.1.3 Microbiology
      • 12.2.1.4 Molecular Diagnostics
      • 12.2.1.5 Hematology
      • 12.2.1.6 Coagulation
  • 12.3 COMPETITIVE SITUATION AND TRENDS
    • 12.3.1 PRODUCT LAUNCHES
    • 12.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 12.3.3 ACQUISITIONS
    • 12.3.4 EXPANSIONS
    • 12.3.5 OTHER STRATEGIES

13 COMPANY PROFILES

(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*

  • 13.1 ROCHE DIAGNOSTICS
  • 13.2 DANAHER CORPORATION
  • 13.3 ABBOTT LABORATORIES, INC.
  • 13.4 SIEMENS AG
  • 13.5 SYSMEX CORPORATION
  • 13.6 THERMO FISHER SCIENTIFIC
  • 13.7 BECTON, DICKINSON AND COMPANY
  • 13.8 BIOMERIEUX SA
  • 13.9 BIO-RAD LABORATORIES, INC.
  • 13.10 JOHNSON & JOHNSON
  • 13.11 AGILENT TECHNOLOGIES
  • 13.12 QIAGEN
  • 13.13 DIASORIN
  • 13.14 ORTHO CLINICAL DIAGNOSTICS (A PART OF CARLYLE GROUP)

Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 NTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.5 AVAILABLE CUSTOMIZATIONS
  • 14.6 RELATED REPORTS
  • 14.7 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GLOBAL IVD MARKET SNAPSHOT
  • TABLE 2: NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2015 VS. 2040 (MILLION INDIVIDUALS)
  • TABLE 3: FULLY AUTOMATED SYSTEMS LAUNCHED BY KEY PLAYERS
  • TABLE 4: NEW TESTS LAUNCHED BY KEY PLAYERS
  • TABLE 5: US: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
  • TABLE 6: US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 7: CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 8: EUROPE: CLASSIFICATION OF IVD DEVICES
  • TABLE 9: EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 10: JAPAN: CLASSIFICATION OF IVD REAGENTS
  • TABLE 11: JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 12: CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 13: INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 14: INDONESIA: REGISTRATION PROCESS FOR IVD DEVICES
  • TABLE 15: RUSSIA: CLASSIFICATION OF IVD DEVICES
  • TABLE 16: SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 17: MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 18: BRAZIL: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 19: SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
  • TABLE 20: IN VITRO DIAGNOSTIC PRODUCTS & SERVICES MARKET: PRODUCT PORTFOLIO ANALYSIS
  • TABLE 21: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 22: IN VITRO DIAGNOSTIC REAGENTS & KITS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 23: IN VITRO DIAGNOSTIC REAGENTS & KITS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 24: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 25: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 26: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 27: MAJOR LAB AUTOMATION SYSTEMS & FULLY AUTOMATED INSTRUMENTS IN THE MARKET
  • TABLE 28: FULLY AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 29: SEMI-AUTOMATED IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 30: OTHER IVD INSTRUMENTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 31: KEY DATA MANAGEMENT SOFTWARE SOLUTIONS AVAILABLE IN THE MARKET
  • TABLE 32: IN VITRO DIAGNOSTIC DATA MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 33: IN VITRO DIAGNOSTIC DATA MANAGEMENT SOFTWARE MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 34: IN VITRO DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 35: IN VITRO DIAGNOSTIC SERVICES MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 36: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 37: IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN THE MARKET
  • TABLE 38: IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 39: IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 40: ELISA ANALYZERS AVAILABLE IN THE MARKET
  • TABLE 41: ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 42: ENZYME-LINKED IMMUNOSORBENT ASSAY MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 43: CHEMILUMINESCENCE IMMUNOASSAY SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 44: CHEMILUMINESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 45: FLUORESCENCE IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 46: COLORIMETRIC IMMUNOASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 47: RADIOIMMUNOASSAY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 48: RAPID TESTS AVAILABLE IN THE MARKET
  • TABLE 49: RAPID TEST MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 50: WESTERN BLOTTING SYSTEMS AVAILABLE IN THE MARKET
  • TABLE 51: WESTERN BLOTTING MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 52: ELISPOT ASSAYS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 53: CLINICAL CHEMISTRY ANALYZERS FOR HIGH- AND MID-VOLUME LABORATORIES
  • TABLE 54: CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES
  • TABLE 55: BLOOD GAS ANALYZERS AVAILABLE IN THE MARKET
  • TABLE 56: CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 57: CLINICAL CHEMISTRY MARKET, BY TEST TYPE, 2016-2023 (USD MILLION)
  • TABLE 58: BASIC METABOLIC PANEL MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 59: ELECTROLYTE PANEL MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 60: LIVER PANEL MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 61: LIPID PROFILE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 62: RENAL PROFILE MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 63: THYROID FUNCTION PANEL MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 64: SPECIALTY CHEMICAL TESTS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 65: AUTOMATED MOLECULAR PLATFORMS, BY KEY MARKET PLAYER
  • TABLE 66: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 67: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 68: PCR INSTRUMENTS, BY KEY MARKET PLAYER
  • TABLE 69: PCR MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 70: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 71: MICROARRAY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 72: HYBRIDIZATION MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 73: NGS INSTRUMENTS, BY KEY MARKET PLAYER
  • TABLE 74: DNA SEQUENCING & NGS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 75: OTHER MOLECULAR DIAGNOSTIC TECHNOLOGIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 76: MICROBIOLOGY INSTRUMENTS, BY KEY MARKET PLAYER
  • TABLE 77: MICROBIOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 78: HEMATOLOGY ANALYZERS, BY KEY MARKET PLAYER
  • TABLE 79: HEMATOLOGY MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 80: COAGULATION ANALYZERS, BY KEY MARKET PLAYER
  • TABLE 81: POINT OF CARE/SELF-MONITORING COAGULATION ANALYZERS, BY KEY MARKET PLAYER
  • TABLE 82: COAGULATION & HEMOSTASIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 83: URINALYSIS INSTRUMENTS, BY KEY MARKET PLAYER
  • TABLE 84: URINALYSIS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 85: BLOOD GLUCOSE TESTING SYSTEMS, BY KEY MARKET PLAYER
  • TABLE 86: TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS OFFERED BY KEY MARKET PLAYERS
  • TABLE 87: OTHER IVD TECHNOLOGIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 88: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 89: IN VITRO DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 90: GLOBAL DIABETIC PATIENT POPULATION IN 2015 AND 2040 (MILLION)
  • TABLE 91: IN VITRO DIAGNOSTICS MARKET FOR DIABETES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 92: IN VITRO DIAGNOSTICS MARKET FOR ONCOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 93: IN VITRO DIAGNOSTICS MARKET FOR CARDIOLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 94: IN VITRO DIAGNOSTICS MARKET FOR AUTOIMMUNE DISEASES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 95: IN VITRO DIAGNOSTICS MARKET FOR NEPHROLOGY, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 96: IN VITRO DIAGNOSTICS MARKET FOR DRUG TESTING/PHARMACOGENOMICS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 97: IN VITRO DIAGNOSTICS MARKET FOR HIV/AIDS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 98: IN VITRO DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 99: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 100: IN VITRO DIAGNOSTICS MARKET FOR HOSPITALS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 101: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 102: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 103: LARGE/REFERENCE LABORATORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 104: MEDIUM-SIZED LABORATORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 105: SMALL LABORATORIES MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 106: IN VITRO DIAGNOSTICS MARKET FOR POC TESTING, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 107: IN VITRO DIAGNOSTICS MARKET FOR PATIENT SELF-TESTING, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 108: IN VITRO DIAGNOSTICS MARKET FOR ACADEMIC INSTITUTES, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 109: IN VITRO DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 110: IN VITRO DIAGNOSTICS MARKET, BY REGION, 2016-2023 (USD MILLION)
  • TABLE 111: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 112: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 113: NORTH AMERICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 114: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 115: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 116: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 117: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 118: US: KEY MACROINDICATORS
  • TABLE 119: US: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 120: US: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 121: US: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 122: US: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 123: US: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 124: US: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 125: CANADA: KEY MACROINDICATORS
  • TABLE 126: CANADA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 127: CANADA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 128: CANADA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 129: CANADA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 130: CANADA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 131: CANADA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 132: EUROPE: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 133: EUROPE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 134: EUROPE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 135: EUROPE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 136: EUROPE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 137: EUROPE: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 138: EUROPE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 139: GERMANY: KEY MACROINDICATORS
  • TABLE 140: GERMANY: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 141: GERMANY: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 142: GERMANY: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 143: GERMANY: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 144: GERMANY: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 145: GERMANY: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 146: FRANCE: KEY MACROINDICATORS
  • TABLE 147: FRANCE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 148: FRANCE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 149: FRANCE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 150: FRANCE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 151: FRANCE: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 152: FRANCE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 153: UK: KEY MACROINDICATORS
  • TABLE 154: UK: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 155: UK: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 156: UK: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 157: UK: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 158: UK: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 159: UK: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 160: ITALY: KEY MACROINDICATORS
  • TABLE 161: ITALY: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 162: ITALY: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 163: ITALY: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 164: ITALY: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 165: ITALY: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 166: ITALY: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 167: SPAIN: KEY MACROINDICATORS
  • TABLE 168: SPAIN: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 169: SPAIN: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 170: SPAIN: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 171: SPAIN: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 172: SPAIN: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 173: SPAIN: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 174: RUSSIA: KEY MACROINDICATORS
  • TABLE 175: RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 176: RUSSIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 177: RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 178: RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 179: RUSSIA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 180: RUSSIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 181: ROE: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 182: ROE: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 183: ROE: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 184: ROE: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 185: ROE: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 186: ROE: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 187: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016-2023 (USD MILLION)
  • TABLE 188: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 189: ASIA PACIFIC: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 190: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 191: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 192: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 193: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 194: JAPAN: KEY MACROINDICATORS
  • TABLE 195: JAPAN: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 196: JAPAN: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 197: JAPAN: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 198: JAPAN: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 199: JAPAN: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 200: JAPAN: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 201: CHINA: KEY MACROINDICATORS
  • TABLE 202: CHINA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 203: CHINA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 204: CHINA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 205: CHINA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 206: CHINA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 207: CHINA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 208: INDIA: KEY MACROINDICATORS
  • TABLE 209: INDIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 210: INDIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 211: INDIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 212: INDIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 213: INDIA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 214: INDIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 215: SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 216: SOUTH KOREA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 217: SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 218: SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 219: SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 220: SOUTH KOREA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 221: INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 222: INDONESIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 223: INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 224: INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 225: INDONESIA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 226: INDONESIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 227: ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 228: ROAPAC: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 229: ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 230: ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 231: ROAPAC: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 232: ROAPAC: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 233: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 234: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 235: LATIN AMERICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 236: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 237: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 238: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 239: LATIN AMERICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 240: BRAZIL: KEY MACROINDICATORS
  • TABLE 241: BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 242: BRAZIL: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 243: BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 244: BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 245: BRAZIL: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 246: BRAZIL: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 247: MEXICO: KEY MACROINDICATORS
  • TABLE 248: MEXICO: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 249: MEXICO: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 250: MEXICO: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 251: MEXICO: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 252: MEXICO: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 253: MEXICO: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 254: ROLA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 255: ROLA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 256: ROLA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 257: ROLA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 258: ROLA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 259: ROLA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 260: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY COUNTRY, 2016-2023 (USD MILLION)
  • TABLE 261: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 262: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 263: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 264: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 265: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 266: MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 267: SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 268: SAUDI ARABIA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 269: SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 270: SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 271: SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 272: SAUDI ARABIA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 273: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016-2023 (USD MILLION)
  • TABLE 274: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTIC INSTRUMENTS MARKET, BY TYPE, 2016-2023 (USD MILLION)
  • TABLE 275: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016-2023 (USD MILLION)
  • TABLE 276: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY APPLICATION, 2016-2023 (USD MILLION)
  • TABLE 277: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2016-2023 (USD MILLION)
  • TABLE 278: REST OF MIDDLE EAST AND AFRICA: IN VITRO DIAGNOSTICS MARKET FOR LABORATORIES, BY SIZE, 2016-2023 (USD MILLION)
  • TABLE 279: PRODUCT LAUNCHES, 2014-2018
  • TABLE 280: AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2014-2017
  • TABLE 281: ACQUISITIONS, 2014-2017
  • TABLE 282: EXPANSIONS, 2015-2017
  • TABLE 283: OTHER STRATEGIES, 2014-2017

LIST OF FIGURES

  • FIGURE 1: MARKET SEGMENTATION
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BOTTOM-UP APPROACH
  • FIGURE 4: TOP-DOWN APPROACH
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: IVD MARKET, BY PRODUCT & SERVICE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 7: IVD MARKET, BY APPLICATION, 2018 VS. 2023 (USD BILLION)
  • FIGURE 8: IVD MARKET, BY TECHNOLOGY, 2018 VS. 2023 (USD BILLION)
  • FIGURE 9: IMMUNOCHEMISTRY/ IMMUNOASSAY MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 10: CLINICAL CHEMISTRY MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 11: MOLECULAR DIAGNOSTICS MARKET, BY TYPE, 2018 VS. 2023 (USD BILLION)
  • FIGURE 12: IVD MARKET, BY END USER, 2018 VS. 2023 (USD BILLION)
  • FIGURE 13: GEOGRAPHIC SNAPSHOT OF THE IN VITRO DIAGNOSTICS MARKET
  • FIGURE 14: RISING INCIDENCE OF CHRONIC LIFESTYLE DISEASES IS DRIVING THE GROWTH OF THE IN VITRO DIAGNOSTICS MARKET
  • FIGURE 15: REAGENTS & KITS COMMANDED THE LARGEST SHARE IN 2017
  • FIGURE 16: THE US ACCOUNTED FOR THE LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2017
  • FIGURE 17: APAC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD
  • FIGURE 18: DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH DURING THE FORECAST PERIOD
  • FIGURE 19: IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
  • FIGURE 20: INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 21: INCREASE IN GROSS EXPENDITURE ON R&D IN EMERGING COUNTRIES, 2012-2014
  • FIGURE 22: US: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 23: CANADA: REGULATORY PROCESS FOR IVD DEVICES IN CANADA
  • FIGURE 24: EUROPE: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 25: REGULATORY PROCESS FOR IVD DEVICES IN JAPAN
  • FIGURE 26: INDIA: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 27: MEXICO: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 28: BRAZIL: REGULATORY PROCESS FOR IVD DEVICES
  • FIGURE 29: REAGENTS & KITS SEGMENT TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
  • FIGURE 30: MOLECULAR DIAGNOSTICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 31: RAPID TESTS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD (2018-2023)
  • FIGURE 32: ONCOLOGY, THE FASTEST-GROWING APPLICATION SEGMENT OF THE IN VITRO DIAGNOSTICS MARKET
  • FIGURE 33: NUMBER OF PEOPLE LIVING WITH HIV GLOBALLY, 2010-2015
  • FIGURE 34: IN VITRO DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023 (USD MILLION)
  • FIGURE 35: NUMBER OF HOSPITALS, BY COUNTRY/REGION (2015)
  • FIGURE 36: NUMBER OF LABORATORIES, BY COUNTRY/REGION (2015)
  • FIGURE 37: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES, 2000 VS. 2014
  • FIGURE 38: NORTH AMERICA TO ACCOUNT FOR THE LARGEST SHARE OF THE IN VITRO DIAGNOSTICS MARKET IN 2023
  • FIGURE 39: GEOGRAPHICAL SNAPSHOT OF THE GLOBAL IN VITRO DIAGNOSTICS MARKET
  • FIGURE 40: NORTH AMERICA: IN VITRO DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 41: EUROPE: IN VITRO DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 42: ASIA PACIFIC: IN VITRO DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 43: KEY DEVELOPMENTS IN THE IN VITRO DIAGNOSTIC MARKET FROM 2014 TO 2018
  • FIGURE 44: GLOBAL IN VITRO DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2017
  • FIGURE 45: GLOBAL CLINICAL CHEMISTRY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 46: GLOBAL IMMUNOASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 47: GLOBAL MICROBIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 48: GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 49: GLOBAL HEMATOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 50: GLOBAL CLINICAL COAGULATION ANALYZERS MARKET SHARE ANALYSIS, BY KEY PLAYERS (2017)
  • FIGURE 51: F. HOFFMANN-LA ROCHE.: COMPANY SNAPSHOT (2016)
  • FIGURE 52: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
  • FIGURE 53: ABBOTT LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 54: SIEMENS AG: COMPANY SNAPSHOT (2017)
  • FIGURE 55: SYSMEX CORPORATION: COMPANY SNAPSHOT (2017)
  • FIGURE 56: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2016)
  • FIGURE 57: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2017)
  • FIGURE 58: BIOMERIEUX SA: COMPANY SNAPSHOT (2016)
  • FIGURE 59: BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 60: JOHNSON & JOHNSON: COMPANY SNAPSHOT (2016)
  • FIGURE 61: AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2016)
  • FIGURE 62: QIAGEN: COMPANY SNAPSHOT (2016)
  • FIGURE 63: DIASORIN: COMPANY SNAPSHOT (2016)
Back to Top